Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Director's Dealing 2024

Jun 22, 2024

6965_rns_2024-06-22_27842130-c7ef-4896-b44d-f25ad3f646c5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3

FORM 3 UNITED STATES SECURITIES AND EXCHANGE

COMMISSION Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number: 3235- 0104

Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*
Gabay Avraham
2. Date of Event
(Month/Day/Year)
06/18/2024
3. Issuer Name and Ticker or Trading Symbol
Requiring Statement
ORAMED PHARMACEUTICALS INC.
[ ORMP ]
(Last) (First)
1185 AVENUE OF THE
(Middle) 4. Relationship of Reporting Person(s) to
Issuer
(Check all applicable)
10% Owner
5. If Amendment, Date of Original
Filed (Month/Day/Year)
(Street)
NEW
YORK
AMERICAS, THIRD FLOOR
NY
10036 Director
Officer (give
title below)
Chief Financial Officer
Other (specify
below)
(Check Applicable Line)
Person
Reporting Person
6. Individual or Joint/Group Filing
Form filed by One Reporting
Form filed by More than One
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)
2. Amount of Securities
Beneficially Owned (Instr.
4)
3. Ownership
Form: Direct
(D) or Indirect
(I) (Instr. 5)
4. Nature of Indirect Beneficial
Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and
Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities
Underlying Derivative Security
4.
Conversion
or Exercise
Price of
5.
Ownership
6. Nature of
Indirect Beneficial
Ownership (Instr.
(Instr. 4) Form:
Direct (D)
5)

Explanation of Responses:

No securities are beneficially owned.

/s/ Avraham Gabay 06/21/2024

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.